Background: The role of the immune system in multiple sclerosis (MS) has been proved. Pentoxifylline has an inhibitory effect on phosphodiesterase and the cytokine products. In some studies therapeutic effects of pentoxifylline have been documented in MS patients. Objectives: The aim of our study was to investigate the effects of pentoxifylline on the recurrence and the disease course in MS patients. Patients and Methods:In our double-blinded clinical trial study, 44 newly diagnosed relapsing-remitting MS patients were studied for 12 months. They were divided into 2 groups: in group 1, 22 patients received interferon and oral pentoxifylline (800 mg daily for 2 months) and in group 2 (control group), 22 patients received interferon with a placebo. The monthly attack rates and the clinical condition of the patients, using the expanded disability status scale (EDSS), were measured in 3 different times along the study (beginning of the treatment, 6 months after and at the end of the treatment). Analysis of the data was done using t-test and the nonparametric Mann-Whitney U test. Results: There was not any significant difference between the 2 groups in terms of age and sex. The recurrence in the first year was 0.4% and 0 in group 1 and 2, respectively. Also there was not any difference in the clinical course and the recurrence of the disease between two groups in one year of follow-up. Conclusions: Adding pentoxifylline to interferon does not have any synergistic therapeutic effects on the reduction of relapse frequency and EDSS in patients with relapsing-remitting multiple sclerosis in comparison with interferon.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.